These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Aberdam D; Galliano MF; Vailly J; Pulkkinen L; Bonifas J; Christiano AM; Tryggvason K; Uitto J; Epstein EH; Ortonne JP Nat Genet; 1994 Mar; 6(3):299-304. PubMed ID: 8012394 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of the skin in junctional epidermolysis bullosa using laminin 5 chain specific antibodies is of limited value in predicting the underlying gene mutation. McMillan JR; McGrath JA; Pulkkinen L; Kon A; Burgeson RE; Ortonne JP; Meneguzzi G; Uitto J; Eady RA Br J Dermatol; 1997 Jun; 136(6):817-22. PubMed ID: 9217810 [TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphism in a commonly utilized LAMB3 primer sequence: implications for mutation detection and haplotype analysis in junctional epidermolysis bullosa. Liu L; Choy YS; Wessagowit V; Ozoemena L; Dopping-Hepenstal PJ; Fassihi H; McGrath JA J Dermatol Sci; 2006 Oct; 44(1):48-51. PubMed ID: 16814527 [No Abstract] [Full Text] [Related]
12. Treatment of two patients with Herlitz junctional epidermolysis bullosa with artificial skin bioequivalents. Jiang QJ; Izakovic J; Zenker M; Fartasch M; Meneguzzi G; Rascher W; Schneider H J Pediatr; 2002 Oct; 141(4):553-9. PubMed ID: 12378197 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Pulkkinen L; Christiano AM; Airenne T; Haakana H; Tryggvason K; Uitto J Nat Genet; 1994 Mar; 6(3):293-7. PubMed ID: 8012393 [TBL] [Abstract][Full Text] [Related]
14. Successful Multidisciplinary Treatment of Chronic Facial Wounds in Junctional Epidermolysis Bullosa. Reimer A; Laszig R; Pfeiffer J; Eberwein P; Mittelviefhaus H; Bruckner-Tuderman L; Has C Acta Derm Venereol; 2018 Jul; 98(7):711-712. PubMed ID: 29963681 [No Abstract] [Full Text] [Related]
15. Impact of laminin 5 beta3 gene versus protein replacement on gene expression patterns in junctional epidermolysis bullosa. Robbins PB; Sheu SM; Goodnough JB; Khavari PA Hum Gene Ther; 2001 Jul; 12(11):1443-8. PubMed ID: 11485635 [TBL] [Abstract][Full Text] [Related]
16. Herlitz junctional epidermolysis bullosa: laminin-5 mutational profile and carrier frequency in the Italian population. Castori M; Floriddia G; De Luca N; Pascucci M; Ghirri P; Boccaletti V; El Hachem M; Zambruno G; Castiglia D Br J Dermatol; 2008 Jan; 158(1):38-44. PubMed ID: 17916201 [TBL] [Abstract][Full Text] [Related]
17. Epidermolysis bullosa: where do we stand? Sarkar R; Bansal S; Garg VK Indian J Dermatol Venereol Leprol; 2011; 77(4):431-8. PubMed ID: 21727690 [TBL] [Abstract][Full Text] [Related]
18. Development of bullous pemphigoid in junctional epidermolysis bullosa. Fania L; Provini A; Salemme A; Sinagra JL; Guerra L; Mazzanti C; Didona B; Castiglia D; Di Zenzo G J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):e146-e148. PubMed ID: 31709656 [No Abstract] [Full Text] [Related]